Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LP-003 in Peanut Allergic Patients
NCT07785063Phase 2Not yet recruiting
- Sponsor
- LongBio Pharma
- Start
- Sep 2026
- Primary completion
- May 2029
01
Overview
A Phase 2 trial of LP-003 in peanut allergy, sponsored by LongBio Pharma. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
LP-003
03
Conditions
peanut allergy
Beyond the preview
Go deeper on NCT07785063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07785063.